CYTEIR THERAPEUTICS INC (CYT) Stock Analyst Earnings Estimates
NASDAQ:CYT - Nasdaq - US23284P1030 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10K | N/A -100.00% | 60.704M | 118.54M 95.28% | 181.6M 53.20% | 240.28M 32.31% | |||||||
| EBITDA YoY % growth | -15.89M | N/A -29.58% | -14.438M -102.91% | -16.315M -13.69% | -43.028M 9.41% | 5.937M 113.80% | -49.425M -932.50% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -16.11M | N/A -29.98% | -26.266M -101.81% | -51.391M -13.98% | -43.787M 9.10% | 5.06M 111.56% | -55.947M -1,205.68% | -67.083M -19.90% | -26.509M 60.48% | 8.689M 132.78% | 48.411M 457.15% | 16.127M -66.69% | |
| Operating Margin | -161,100.00% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -43.67% | 7.33% | 26.66% | 6.71% | |
| EPS YoY % growth | N/A | N/A | -2.11 | -1.41 38.30% | -1.09 16.09% | -0.88 19.44% | -0.87 1.15% | -0.79 9.30% | -0.15 80.77% | 0.26 273.33% | 0.71 169.23% | 0.45 -35.71% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.25 -1.00% | -0.25 27.86% | -0.26 -9.42% | -0.27 -8.00% | -0.28 -12.00% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | 12.09M 228.89% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 12.09M 220.30% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -0.24 29.41% | -0.32 | 0.08 | 25.74% |
| Q1 2023 Q2Q % growth | -0.35 12.50% | -0.27 | -0.08 | -29.79% |
| Q4 2022 Q2Q % growth | -0.25 26.47% | -0.35 | 0.10 | 27.73% |
| Q3 2022 Q2Q % growth | -0.31 6.06% | -0.41 | 0.10 | 25.14% |
| Q2 2022 Q2Q % growth | -0.34 92.96% | -0.44 | 0.10 | 23.49% |
| Q1 2022 Q2Q % growth | -0.40 | -0.39 | -0.01 | -1.55% |
| Q4 2021 Q2Q % growth | -0.34 | -0.40 | 0.06 | 14.56% |
| Q3 2021 Q2Q % growth | -0.33 | -0.36 | 0.03 | 9.24% |
| Q2 2021 Q2Q % growth | -4.83 | -1.47 | -3.36 | -227.55% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |